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Alimentary Pharmacology and Therapeutics
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SUMMARY
Background
Crohn’s disease (CD) and ulcerative colitis (UC) are two pathotypes of inﬂammatory
bowel disease (IBD) with unique pathology, risk factors and signiﬁcant morbidity.
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To estimate incidence and identify IBD risk factors in a US military population, a
healthy subset of the US population, using information from the Millennium
Cohort Study.

Methods
Incident IBD was identiﬁed from medical encounters from 2001 to 2009 or by
self-report. Our primary risk factor of interest, infectious gastroenteritis, was identiﬁed from medical encounters and self-reported post-deployment health assessments. Other potential risk factors were assessed using self-reported survey
responses and military personnel ﬁles. Hazard ratios were estimated using Cox
proportional hazards analysis.

Results
We estimated 23.2 and 21.9 diagnoses per 100 000 person-years, respectively, for
CD and UC. For CD, signiﬁcant risk factors included [adjusted hazard ratio (aHR),
95% conﬁdence interval]: current smoking (aHR: 2.7, 1.4–5.1), two life stressors
(aHR: 2.8, 1.4–5.6) and prior irritable bowel syndrome (aHR: 4.7, 1.5–15.2). There
was no signiﬁcant association with prior infectious gastroenteritis. There was an
apparent dose–response relationship between UC risk and an increasing number of
life stressors. In addition, antecedent infectious gastroenteritis was associated with
almost a three-fold increase in UC risk (aHR: 2.9, 1.4–6.0). Moderate alcohol consumption (aHR: 0.4, 0.2–0.6) was associated with lower UC risk.

Conclusions
Stressful conditions and the high risk of infectious gastroenteritis in deployment
operations may play a role in the development of IBD in military populations.
However, observed differences in risk factors for UC and CD warrant further
investigation.
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INTRODUCTION
Inﬂammatory bowel disease (IBD) comprises a group of
bowel diseases of likely immune-mediate aetiology and
primarily occurs in two forms, chronic inﬂammatory
enteritis [Crohn’s Disease(CD)] and chronic inﬂammatory colitis [ulcerative colitis (UC)]. Incidence rates in
North America have been estimated to range from
approximately 2 to 15 cases per 100 000 person-years
for both forms with peak onset between the ages of 15
and 30 years.1–3 In contrast, throughout much of the
developing world, rates are lower; however, IBD incidence appears to be increasing in those regions that are
becoming more westernised.4, 5 The symptoms of IBD
include abdominal pain, vomiting, diarrhoea, hematochezia, weight loss and weight gain and treatments can
involve immunosuppression and/or surgery with direct
medical costs in the USA exceeding $1.8 billion,6 and
indirect costs due to lost work production alone estimated to exceed $3.6 billion annually.7
The challenges of population-based epidemiologic
studies of IBD include confounding by co-morbid conditions and/or limited data on risk factors and/or speciﬁc
study populations compromising validity and limiting
generalisability.8 One population that may be well-suited
to study disease incidence is active duty US military personnel. The US active duty military population represents a healthier segment of the general population with
almost unrestricted access to available medical care,
which makes them suitable for epidemiologic studies on
disease incidence and risk factors, due to the likely capture of these outcomes from the military health care system. Prior studies in military populations have identiﬁed
important and unique risk factors, but have been limited
to data available in electronic medical records which
often lack detailed information on life stressors and
health risk behaviours that may be important in understanding the epidemiology of disease.9–11 To address
these limitations, we utilised a hypothesis-generating
approach in leveraging data from the Millennium Cohort
Study, a large prospective study of more than 200 000
military service members that includes a triennial survey
of health conditions, to describe IBD incidence and
assess potential risk factors not previously explored in
this population.
MATERIALS AND METHODS
Study population
Launched in 2001, the Millennium Cohort Study is a
prospective longitudinal study to investigate any impact
1116

of military service among US military personnel even
after separation from military service. The methodology
has previously been described elsewhere.12–14 The cohort
contains four enrolment panels (Panel 1, 2001–2003,
N = 77 019; Panel 2, 2004–2006, N = 31 110; Panel 3,
2007–2008,
N = 43 439;
Panel
4,
2011–2013,
N = 50 052). Panel 1 was a population-based random
sample of the U.S. military in October 2000 with oversampling of Reserve/Guard personnel, women, and those
deployed to Bosnia, Kosovo or Southwest Asia. Panels 2,
3 and 4 targeted new accessions (1–5 years of military
service) with oversampling of Marines and women. Participants completed a baseline survey and were resurveyed at approximately 3-year intervals. For purposes of
our study, we focused on responses to two questions:
whether the participant had been diagnosed by a healthcare provider with either 1) CD, or 2) UC or proctitis.
The population for this IBD study was deﬁned as
active duty Millennium Cohort Study participants from
Panels 1 and 2 who completed a baseline questionnaire
(while still serving in the military) and at least one follow-up questionnaire between 2001 and 2009. Participants with evidence of IBD at baseline, either by selfreport on the baseline survey or from Military Health
System medical encounter (ME) data (≥2 MEs within
365 days with one or more of the following International
Classiﬁcation of Diseases, 9th Revision, Clinical Modiﬁcation (ICD-9-CM) codes: 555.0, 555.1, 555.9, 556.x),
were excluded from this analysis. Self-report of provider
diagnosed “ulcerative colitis or proctitis” was also exclusionary because even though proctitis is not a type of
IBD, the survey question precluded disease differentiation. In addition, participants who reported they had
received a diagnosis of every listed health outcome (panendorsers) on any survey questionnaire were excluded as
were subjects with incomplete data for risk factors of
interest.

Incident IBD
Incident IBD was determined based on medical encounter data or self-report as follows. Active duty participants
with ≥2 MEs for IBD (ICD-9-CM codes 555.0, 555.1 and
555.9 for CD and ICD-9-CM code 556.x for UC, in any
diagnostic ﬁeld) within a 365 day period were considered
incident IBD cases. Self-reported CD was deﬁned as a
participant responding “yes” to having been diagnosed
with CD by a provider on a follow-up Millennium
Cohort Study questionnaire. Due to the inability to differentiate UC and proctitis in the Millennium Cohort
Study questionnaire data, only medical encounter data
Aliment Pharmacol Ther 2017; 45: 1115–1127
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were utilised to identify incident UC cases. For diagnoses
derived from medical encounter data only, the date of
the ﬁrst of the two encounters was identiﬁed as the diagnosis date. For self-reported CD, respondents had the
option to report the year of diagnosis. If year of diagnosis was documented, we used the mid-point of the selfreported year. However, if no year was reported, we used
the survey date for their ﬁrst self-reported CD diagnosis.
In cases where a subject met both the medical encounter
deﬁnition and the self-reported deﬁnition of IBD, the
diagnosis date derived from medical encounter data was
preferentially used.

Primary risk factor of interest: antecedent infectious
gastroenteritis
Infectious gastroenteritis data were collected from both
ME data and self-reported post-deployment health
assessments. Medical encounters between the baseline
survey and IBD diagnosis (cases) or censor (noncases)
with an infectious gastroenteritis-associated ICD-9-CM
code (all 001 subgroups, 003.0, 003.9, all 004 subgroups,
all 008.0 subgroups, 008.43, 008.44, 005.4, 008.47,
008.49, 008.5, 009.0, 009.1, 009.2, 009.3, all 005.8 subgroups, 005.9, 006.0, 006.1, 006.2, 006.9, all 007 subgroups, all 008.6 subgroups, and 008.8) were deﬁned as
infectious gastroenteritis episodes. In addition, selfreported diarrhoea during or after deployment on a
post-deployment health assessment completed between
the baseline survey and censoring were considered infectious gastroenteritis episodes. As with IBD, for diagnoses
of infectious gastroenteritis derived from medical
encounter data, the date of the ﬁrst of the two encounters was identiﬁed as the diagnosis date. For selfreported episodes of diarrhoea, the date of completion
of the post-deployment health assessment was used as
the diagnosis date.
Other risk factors
Demographic and military-speciﬁc data, including sex,
birth year, education, marital status, race/ethnicity,
branch of service, occupation, rank, military separation,
deployment status and number of deployments, were
obtained from Defense Manpower Data Center records
and the Millennium Cohort questionnaires. Body mass
index (BMI) was calculated from self-reported height
and weight. Behavioral and mental health characteristics,
including smoking, drinking, life stressors, depression,
anxiety or post-traumatic stress disorder (PTSD), as well
as self-reported medications for these conditions, were
also assessed from Millennium Cohort survey responses.
Aliment Pharmacol Ther 2017; 45: 1115–1127
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Detailed deﬁnitions of each of these risk factors have
been described elsewhere.15

Time censoring calculations
The date of the ﬁrst survey’s submission was deﬁned as
the start time for the period of observation. Noncases
were then censored differently for CD and UC analyses.
For UC, censoring at the earliest of four dates: date of
UC diagnosis; date of separation from military service;
date of death; end of study (31 December 2009). The use
of the survey-based diagnosis for CD complicated censoring. Similar to UC, the date of diagnosis, the date of
death, and the end of the study were censoring events.
In contrast, for those who separated after completion of
their last survey, the censoring date was the date of separation. For those who separated before completion of
their last survey, the date of the last Millennium Cohort
survey completion was the censor date.
Statistical analysis
Survival analyses were performed using the PHREG procedure in SAS (Version 9.3, SAS Institute, Cary, NC,
USA) for CD and UC, modelled separately. The primary
exposure of interest, antecedent infectious gastroenteritis,
was forced into all models as a time-varying covariate.
Forward selection with a P < 0.05 threshold was used
for all other risk factors entering into the model; all of
these variables were examined as ﬁxed effects. Confounders of the infectious gastroenteritis-CD relationship
or infectious gastroenteritis-ulcerative colitis relationship
in their respective models were included if they changed
the IGE parameter estimate by 10% or more. Interactions between infectious gastroenteritis and each covariate in the model were examined. If an interaction term
was signiﬁcant at P < 0.05, Akaike information criterion
was used to select between models with and without the
interaction term. If Akaike information criterion difference between two models was less than four, the model
without interaction term was selected for model parsimony and interpretability.16 Proportional hazards
assumption was examined using Martingale residuals
and interaction with time methods.
RESULTS
Of the 108 129 participants from Panels 1 and 2 who
completed a baseline questionnaire, 203 pan-endorsers of
provider-based diagnoses on at least one survey were
excluded (Figure 1). We were unable to calculate an
accurate censoring time on an additional 39 723 participants, because they were not on active duty for the
1117
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108 129 service members completed
baseline surveys from Panels 1 and 2

Excluded 203 for “pan-endorsing,” meaning
they self -reported on at least one survey that
they were diagnosed by a healthcare provider
with every condition listed

107 926 service members included
Excluded 39,723 who did not meet study
definition of “active duty” (remained on active
duty for the duration of the study, separated
directly from active duty, or entered the
Reserves after active duty only due to term
fulfillment)
68 203 active duty participants

Excluded 18 999 with no follow-up survey

49 204 participants who responded to
at least one follow-up survey

Excluded 4687 for not being “at risk” for IBD
328 had IBD at baseline
4359 separated from the military prior
to completion of baseline survey

44 517 participants “at risk” for IBD

Excluded 3217 from ulcerative colitis

Excluded 3710 from Crohn’s disease

analyses for incomplete covariate data

analyses for incomplete covariate data

41 300 included in ulcerative colitis

40 807 included in Crohn’s disease

analyses (223 387.47 person-years)

analyses (246 673.48 person-years)

Figure 1 | Subject selection for analysis.
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entire course of study and did not have precise separation date. These subjects were excluded from the analysis. Participants were also excluded if they failed to
complete a follow-up survey (n = 18 999) or had IBD at
baseline (n = 328), separated from the military before
the completion of the baseline survey (n = 4359), or had
missing values on risk factors of interest (UC: n = 3217;
CD: n = 3710). Compared to included subjects, excluded
subjects were older (19.8% vs. 8.9% born before 1960),
more commonly single (43.1% vs. 23.1%), in the Army
(52.1% vs. 40.4%), more commonly had life stressors
(77.1% vs. 57.5%), and more frequently had no deployment history at baseline (57.0% vs. 40.9%).
These exclusions yielded a ﬁnal study population of
40 807 participants with 246 673.48 person-years of follow-up for CD, and 41 300 participants with 223 387.47
person-years of follow-up for UC ulcerative colitis.
Demographic, military and behavioural characteristics
of study participants are shown in Table 1. Nearly, three
quarters of the study population were male (72.8%), with
the majority born between 1960 and 1979 (71.6%), married (69.6% for CD and 70.6% for UC), with less than a
bachelor’s degree (69.7% for CD and 69.9% for UC), and
being of white, nonHispanic race/ethnicity (66.1 for CD
and 66.2% for UC). Approximately 40% of the study
population served in the Army, followed by the Air
Force, Navy/Coast Guard and Marine Corps. A majority
of participants were never smokers, followed by former
smokers and current smokers. Approximately half of the
participants reported moderate alcohol consumption,
and over 50% reported having one or more life stressors;
however, only a small proportion of participants
reported experiencing depression, anxiety/panic or
PTSD. With regard to military experience, approximately
60% of the participants had at least one deployment, and
about 26% of the participants reported combat exposure.
A total of 58 new onset CD cases were identiﬁed, for
an incidence of 23.15/100 000 person-years [95% CI
18.20–30.37] with approximately 80% identiﬁed from
either the medical encounter data only (21/58; 36.2%) or
the survey only (24/58; 41.4%). As shown in Table 2,
younger age [born 1980 or later, hazard ratio (HR):
2.07], service and supply occupation (HR: 3.52), anxiety
(HR: 2.62) and prior Irritable bowel syndrome (IBS)
(HR: 5.08) were all associated with signiﬁcantly increased
CD risk. Both current (HR: 2.78) and past (HR: 1.54)
smoking were associated with an increased CD risk,
though only current smokers had a signiﬁcantly
increased risk (P = 0.0011). An increasing number of life
stressors was also associated with an increased CD risk
Aliment Pharmacol Ther 2017; 45: 1115–1127
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with an apparent dose–response effect. Several psychological co-morbidities were associated with increased CD
risk, including anxiety syndrome (HR: 2.62) and PTSD
(HR: 1.82), though the latter was not signiﬁcant. Infectious gastroenteritis was not associated with a signiﬁcant
increase in developing CD (HR: 1.05, 95% CI: 0.47–2.36)
though a nonsigniﬁcant increase in the effect estimate
(HR: 1.94, 95% CI: 0.70–5.41) was observed when limiting to medical encounter only infectious gastroenteritis
episodes (data not shown). Being married (HR: 0.49)
was associated with a decreased CD risk compared to
being single. In addition, there was an inverse association
between BMI and CD risk with those classiﬁed as overweight or obese having lower CD risk (HR: 0.54, 95%
CI: 0.31–0.93 and HR: 0.36, 95% CI: 0.14–0.93 respectively). Military deployments similarly appeared to be
associated with a decreased CD risk, though the effect
was not statistically signiﬁcant. In the adjusted Cox proportional hazards model, service and supply occupation
[adjusted hazard ratio (aHR): 3.32], current smoking
(aHR: 2.65), two life stressors (aHR: 2.75) and prior IBS
(aHR: 4.70) remained associated with a signiﬁcantly
increased CD risk while being married (aHR: 0.53) and
divorced, widowed, legally separated (aHR: 0.12),
remained associated with a decreased CD risk.
There were 49 reported new onset UC cases, yielding
an estimated incidence of 21.94/100 000 person-years
(95% CI: 16.60–28.98). In univariate Cox models, similar
to CD, there were speciﬁc occupational risk factors with
work in electrical and equipment repair (univariate HR
3.43) associated with a signiﬁcantly increased UC risk
(Table 2). In addition, there was an increasing UC hazard ratio with increasing number of life stressors (1:
1.25, 2: 2.12, 3 + : 4.84). Documented infectious gastroenteritis was associated with an increased risk of UC
(HR: 2.62, 95% CI: 1.28–5.37), an effect that increased to
4.86 (95% CI: 2.14–11.05) when limiting analyses to only
medical encounter-related infectious gastroenteritis
events (data not shown). Similar to CD, prior IBS was
associated with increased UC risk (univariate HR: 3.71),
but unlike CD, this effect was not signiﬁcant. Being of
younger age (born 1980 or later, HR: 0.20), married
(HR: 0.51) and moderate alcohol consumption (HR:
0.34) were associated with signiﬁcantly decreased UC
risk. In contrast to CD, current smoking was associated
with a nonsigniﬁcantly decreased risk of UC, and a
slight, nonsigniﬁcantly increased UC risk was observed
among past smokers. Similar to CD, UC risk was lower
in subjects with prior deployments, though the effect was
not statistically signiﬁcant.
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Table 1 | Overall descriptive characteristics of study population included for Crohn’s disease and ulcerative colitis
Crohn’s
(N = 40 807)
Characteristic
Gender
Male
Female
Birth year
Pre-1960
1960–1969
1970–1979
1980-present
Race/ethnicity
White, non-Hispanic
Black, non-Hispanic
Other
Marital status
Single
Married
Divorced, widowed, legally separated
Education
Less than a bachelor’s degree
Bachelor’s degree or higher
Panel (accession into cohort study)
2001–2003
2004–2006
Branch of service
Army
Navy/Coast Guard
Marine Corps
Air Force
Rank
Enlisted
Ofﬁcer
Occupation
Combat specialist
Functional support
Service and supply
Healthcare
Electrical/mechanical equipment repair
Other
Separated
No
Yes
Smoking*
Never
Former
Current
Alcohol consumption†
Abstainer/light
Moderate
Heavy
BMI‡
Normal/underweight
Overweight
Obese

1120

n

disease

Ulcerative
(N = 41 300)

colitis

%

n

%

29 711
11 096

72.8
27.2

30 071
11 229

72.8
27.2

3588
13 344
15 876
7999

8.8
32.7
38.9
19.6

3635
13 574
16 002
8089

8.8
32.9
38.7
19.6

26 993
5487
8327

66.1
13.4
20.4

27 349
5553
8398

66.2
13.4
20.3

9693
28 413
2701

23.8
69.6
6.6

9510
29 177
2613

23.0
70.6
6.3

28 423
12 384

69.7
30.3

28 875
12 425

69.9
30.1

30 329
10 478

74.3
25.7

30 701
10 599

74.3
25.7

16 546
9123
2576
12 562

40.5
22.4
6.3
30.8

16 679
9197
2609
12 815

40.4
22.3
6.3
31.0

30 118
10 689

73.8
26.2

30 438
10 862

73.7
26.3

7802
8245
3475
4554
5720
11 011

19.1
20.2
8.5
11.2
14.0
27.0

7 835
8 499
3483
4624
5766
11 093

19.0
20.6
8.4
11.2
14.0
26.9

23 012
17 795

56.4
43.6

23 012
18 288

55.7
44.3

23 586
10 315
6906

57.8
25.3
16.9

23 896
10 449
6955

57.9
25.3
16.8

16 947
20 644
3216

41.5
50.6
7.9

16 809
21 331
3160

40.7
51.6
7.7

13 612
20 991
6204

33.4
51.4
15.2

13 708
21 393
6199

33.2
51.8
15.0
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Table 1 | (Continued)
Crohn’s
(N = 40 807)
Characteristic
Number of life stressors§
0
1
2
3+
Depression¶
Never
Ever
Anxiety and panic¶
Never
Ever
PTSD**
Never
Ever
Self-reported prescribed medication for mental health
No
Yes
Deployment experience††
Neither
Before OEF/OIF only
OEF/OIF only
Both
Combat exposure‡‡
Not deployed
Deployed, no combat
Deployed, combat
Multiple deployments
0
1
2+

disease

n

Ulcerative
(N = 41 300)

colitis

%

n

%

18 310
15 981
4680
1836

44.9
39.2
11.5
4.5

17 662
16 251
5221
2166

42.8
39.3
12.6
5.2

39 180
1627

96.0
4.0

39 565
1735

95.8
4.2

39 269
1538

96.2
3.8

39 565
1735

95.8
4.2

38 600
2207

94.6
5.4

38 941
2359

94.3
5.7

38 766
2041

95.0
5.0

39 102
2198

94.7
5.3

10 853
5726
14 837
9391

26.6
14.0
36.4
23.0

11 009
5794
15 004
9493

26.7
14.0
36.3
23.0

16 579
13 226
10 523

41.1
32.8
26.1

16 803
13 158
10 640

41.4
32.4
26.2

16 579
12 188
12 040

40.6
29.9
29.5

16 803
12 312
12 185

40.7
29.8
29.5

* Never: self-reported smoking <100 cigarettes in their lifetime. Past smoking: reporting successful smoking cessation, Current:
reported never trying to quit or unsuccessful at quitting.
† No/light: self-reported 0 drinks on a typical week, Moderate: self-reported an average of 1–7 drinks per week for women and 1
–14 per week for men, Heavy: self-reported an average of >7 drinks per week for women and >14 per week for men.
‡ Normal/underweight, <25; overweight, 25–29.9, obese, 30+.
§ Assessed using the Social Readjustment Rating Scale.46
¶ Assessed using responses to the Patient Health Questionnaire.
** Assessed using responses to the PTSD Checklist- Civilian Version.
†† Previous deployments include only Kosovo, Bosnia, SW Asia, and 1991 GW.
‡‡ MISSING: Combat exposures n = 479 (Crohn’s disease); n = 699 (Ulcerative colitis).

In the adjusted Cox proportional hazards models, the
associations between UC and younger age (born 1980 or
later, aHR: 0.15), being married (aHR: 0.37), electrical/
mechanical equipment repair occupation (aHR: 2.96)
and moderate alcohol consumption (aHR: 0.35)
remained. Increasing number of life stressors continued
to demonstrate an association with increasing UC risk
which only reached signiﬁcance in those with 3 +
Aliment Pharmacol Ther 2017; 45: 1115–1127
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stressors (aHR: 5.07, 95% CI: 1.93–13.30). In addition,
the risk of ulcerative colitis associated with antecedent
infectious gastroenteritis remained signiﬁcant in the
adjusted Cox proportional hazards models (aHR: 2.90).
Signiﬁcant interaction was observed between infectious
gastroenteritis and occupation; however, the data were
sparse due to the large number of occupation categories,
such that there, were UC cases with infectious
1121
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Table 2 | Risk factors associated with Crohn’s disease and ulcerative colitis in the Millennium Cohort Study
participants between 2001 and 2009* (N = 40 807 and 41 300 for Crohn’s disease and ulcerative colitis
respectively)
Crohn’s disease
Characteristic

N

Univariate HR

Ulcerative colitis
Adjusted HR

N

Univariate HR

Antecedent infectious gastroenteritis
None
51
Ref
Ref
38
Ref
Any
7 1.05 (0.47–2.36)
1.10 (0.47–2.53)
11 2.62 (1.28–5.37)
Gender
Male
44
Ref
36
Ref
Female
14 0.91 (0.5–1.67)
13 1.04 (0.55–1.97)
Birth year
Pre-1960
6 1.35 (0.54–3.34)
3 0.63 (0.19–2.07)
1960–1969
16 0.90 (0.47–1.72)
17 0.75 (0.41–1.38)
1970–1979
21
Ref
27
Ref
1980-present
15 2.07 (1.06–4.08)
2 0.20 (0.05–0.84)
Race/ethnicity
White non-Hispanic
42
Ref
33
Ref
Black non-Hispanic
6 0.69 (0.29–1.62)
6 0.87 (0.36–2.07)
Other
10 0.74 (0.37–1.47)
10 0.92 (0.45–1.86)
Marital status
Single
20
Ref
Ref
15
Ref
Married
37 0.49 (0.29–0.86) 0.53 (0.30–0.92) 31 0.51 (0.27–0.95)
Divorced, widowed, legally separated
1 0.14 (0.02–1.04) 0.12 (0.02–0.89)
3 0.53 (0.15–1.84)
Education
Less than a bachelor’s degree
40 1.08 (0.62–1.88) 0.65 (0.35–1.21)
37 1.56 (0.81–2.99)
Bachelor’s degree or higher
18
Ref
Ref
12
Ref
Panel
2001–2003
44
Ref
40
Ref
2004–2006
14 1.52 (0.81–2.85)
9 0.93 (0.44–1.95)
Branch of service
Army
21 1.00 (0.52–1.92) 0.86 (0.44–1.68) 14 0.65 (0.32–1.31)
Navy/Coast Guard
17 1.49 (0.75–2.94)
1.19 (0.60–2.38) 15 1.30 (0.65–2.61)
Marine Corps
4 1.31 (0.44–3.93)
1.13 (0.37–3.42)
3 1.00 (0.29–3.43)
Air Force
16
Ref
Ref
17
Ref
Rank
Enlisted
43
Ref
39
Ref
Ofﬁcer
15
1.15 (0.64–2.07)
10 1.67 (0.83–3.34)
Occupation
Combat specialist
8
Ref
Ref
6
Ref
Functional support
6 0.71 (0.25–2.04) 0.67 (0.23–1.95)
10 1.53 (0.56–4.21)
Service and supply
12 3.52 (1.44–8.62) 3.32 (1.35–8.21)
4 1.56 (0.44–5.53)
Healthcare
6 1.33 (0.46–3.83)
1.15 (0.39–3.37)
4
1.13 (0.32–4.01)
Electrical/mechanical equipment
11 2.00 (0.81–4.98) 1.79 (0.69–4.65) 14 3.43 (1.32–8.94)
repair
Other
15 1.39 (0.59–3.29) 1.25 (0.52–2.98)
11 1.36 (0.50–3.67)
Smoking‡
Never
24
Ref
Ref
28
Ref
Past
16 1.54 (0.82–2.90) 1.57 (0.82–2.98) 19 1.61 (0.90–2.88)
Current
18 2.78 (1.51–5.12)
2.64 (1.38–5.07)
2 0.28 (0.07–1.16)
Alcohol consumption§
No/light
27
Ref
33
Ref
Moderate
25 0.74 (0.43–1.28)
15 0.34 (0.19–0.63)
Heavy
6 1.27 (0.52–3.07)
1 0.18 (0.02–1.29)
BMI¶
Normal/underweight
28
Ref
18
Ref
Overweight
25 0.54 (0.31–0.93)
27 0.89 (0.49–1.62)
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Adjusted HR
Ref
2.90 (1.39–6.04)

0.73 (0.22–2.46)
0.85 (0.46–1.58)
Ref
0.15 (0.04–0.64)

Ref
0.37 (0.19–0.70)
0.35 (0.10–1.27)

0.60 (0.29–1.24)
1.18 (0.58–2.42)
1.10 (0.32–3.80)
Ref

Ref
1.19
1.29
0.84
2.96

(0.43–3.30)
(0.36–4.60)
(0.23–3.01)
(1.12–7.82)

1.12 (0.41–3.05)
Ref
1.59 (0.88–2.89)
0.25 (0.06–1.07)
Ref
0.35 (0.19–0.64)
0.16 (0.02–1.19)
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Table 2 | (Continued)
Crohn’s disease
Characteristic

N

Univariate HR

Obese
5 0.36 (0.14–0.93)
Number of life stressors**
0
20
Ref
1
21 1.25 (0.68–2.30)
2
13 2.86 (1.42–5.75)
3+
4 2.50 (0.85–7.32)
Depression syndrome ††
No
56
Ref
Yes
2 0.96 (0.23–3.92)
Anxiety syndrome††
No
53
Ref
Yes
5 2.62 (1.05–6.55)
PTSD‡‡
No
53
Ref
Yes
5 1.82 (0.73–4.55)
Self-reported prescribed medication for mental health
No
54
Ref
Yes
4 1.44 (0.52–3.97)
Deployments
0
26
Ref
1
17 0.86 (0.47–1.58)
2+
15 0.73 (0.39–1.38)
Prior IBS
No
55
Ref
Yes
3 5.08 (1.59–16.23)

Ulcerative colitis
Adjusted HR

N
4

Ref
1.21 (0.66–2.25)
2.75 (1.35–5.62)
2.25 (0.75–6.75)

Univariate HR

Adjusted HR

0.45 (0.15–1.33)

17
Ref
18 1.25 (0.64–2.42)
8 2.12 (0.91–4.91)
6 4.84 (1.90–12.33)
47
2

Ref
1.15 (0.28–4.72)

48
1

Ref
0.55 (0.08–3.96)

45
4

Ref
1.70 (0.61–4.72)

46
3

Ref
1.22 (0.38–3.92)

Ref
0.82 (0.44–1.53)
0.72 (0.37–1.40)

21
13
15

Ref
0.71 (0.35–1.42)
0.75 (0.39–1.46)

Ref
4.70 (1.46–15.15)

47
2

Ref
3.71 (0.90–15.28)

Ref
1.23 (0.63–2.40)
2.19 (0.93–5.16)
5.07 (1.93–13.30)

IBS, irritable bowel syndrome.
* Excludes pan endorsers and anyone who did not complete at least one follow-up survey.
‡ Never: self-reported smoking <100 cigarettes in their lifetime. Past smoking: reporting successful smoking cessation, Current:
reported never trying to quit or unsuccessful at quitting.
§ No/light: self-reported 0 drinks on a typical week, Moderate: self-reported an average of 1–7 drinks per week for women and 1
–14 per week for men, Heavy: self-reported an average of >7 drinks per week for women and >14 per week for men.
¶ Normal/underweight, <25; overweight, 25–29.9, obese, 30+.
** Assessed using the Social Readjustment Rating Scale.46
†† Assessed using responses to the Patient Health Questionnaire.
‡‡ Assessed using responses to the PTSD Checklist- Civilian Version.

gastroenteritis in only two occupation categories, healthcare and electrical/mechanical equipment repair (data
not shown).

DISCUSSION
In our population of current and former military members, we estimated an overall UC and CD incidence of
21.94 and 23.15/100 000 person-years respectively.
Importantly, subjects with missing data on important
risk factors for the survival analyses were excluded from
these estimates though their exclusion yielded no substantial change in overall incidence for either CD or UC
Aliment Pharmacol Ther 2017; 45: 1115–1127
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(data not shown). Several prior studies have estimated
the incidence of CD and UC in various populations with
comparable estimates.17 In the USA, studies reporting
CD and UC incidence in comparably aged populations
have estimated CD incidence between 5.7 and 28.4 per
100,000 person-years with a slightly higher incidence of
UC reported in some studies.1, 18, 19 We observed no
signiﬁcant difference in the incidence of CD and UC in
our study. A single study has previously reported overall
IBD incidence (CD and UC) in this population at just
less than 30 cases per 100 000 person-years10; however,
that study was limited to medical encounters occurring
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during the active duty service period which may account
for the lower rates than reported here.
On the basis of several prior lines of evidence, we took
a focused look at the role of infectious gastroenteritis in
increasing IBD risk. While we observed no association
between CD incidence and infectious gastroenteritis, we
did see an almost three-fold increase in UC incidence in
subjects with prior infectious gastroenteritis. Separate
studies have previously reported a positive association
between antecedent Campylobacter and Salmonella infection and IBD 20, 21 while others have noted an association with nonspeciﬁc exposures such as those included
in our models.10, 22 While studies of the potential mechanisms underlying this association are in their infancy,
in vivo and in vitro data are emerging that may increase
understanding of these ﬁndings. To that end, recent data
show that C. jejuni facilitates the translocation of commensal ﬂora leading to the aberrant immune response
seen in IBD patients.23 In addition, data are emerging
that suggest a proliferation of anti-commensal T cells is
evident following an acute gastrointestinal (GI) infection
which coincides with a loss in regulatory T cells.24, 25
Furthermore, increased levels of antibodies directed at
commensal ﬂora are evident in the serum of IBD
patients; however, similar commensal responses present
in healthy populations points to a more nuanced effect
that may be based on genetic predisposition, repeated
exposure or extra-intestinal exposures.24
In contrast to other studies, we found no association
between infectious gastroenteritis and CD.10, 20–22 This
may be due to nondifferential exposure misclassiﬁcation;
however, studies using similar exposures and those
focused on Campylobacter and Salmonella reported comparable positive association between infectious gastroenteritis and both IBD pathotypes. Importantly, there were
differences in how incident CD and UC cases were identiﬁed. Speciﬁcally, incident CD was identiﬁed from both
the medical encounter data as well as an afﬁrmative
response on the Millennium Cohort Study questionnaire.
In contrast, UC cases were limited to medical encounter
data. Given the prior report of 17.1% positive agreement
between CD-speciﬁc Millennium Cohort responses and
corresponding medical records,26 we re-ran our analyses
including only cases identiﬁed by medical encounter data
in an attempt to assess whether inclusion of self-reported
diagnosis introduced case-status misclassiﬁcation. In that
re-analysis, we found a nonsigniﬁcant 1.5-fold increase
in CD risk among those with prior infectious gastroenteritis (data not shown). Similarly, we also assessed the
role of infectious gastroenteritis identiﬁed solely from
1124

medical encounter data to minimise potential biases in
self-reported exposures. The adjusted HR for antecedent
infectious gastroenteritis in the UC model increased to
4.4 (95% CI: 1.9–10.0) and to 1.6 for CD (95% CI: 0.6–
4.6), though not statistically signiﬁcant (data not shown).
While the mechanisms behind the association between
acute enteric infection and IBD are unclear, this is not
the only study to report this association.10, 20–22 It is
possible that the observation represents an increased risk
of infectious gastroenteritis (or even severe gastroenteritis) in those with undiagnosed IBD. While this is feasible, other studies reporting this phenomenon have
described a delay in the observed effect (development of
IBD following infectious gastroenteritis) of more than
5 years.10, 20–22 In our study, the median time was
approximately 2.5 years. While again, this may represent
subclinical IBD that likelihood is reduced the more distal
in time from the antecedent infectious gastroenteritis
episode.
It has been argued that the association between antecedent enteric infection and increased IBD risk may be
due to diagnostic misclassiﬁcation due to increased culturing in the IBD work-up.21 While this may in fact play
a role, the data to date are insufﬁcient to support this
purported bias and carefully designed studies are needed
to assess the role of a surveillance bias and include the
clinical presentation of subjects at the time of culture.27
In our study, CD was most strongly linked to antecedent IBS after controlling for other risk factors (adjusted
HR: 4.70; P = 0.01); however, there was no association
with UC in the multivariable model. Garcia-Rodriguez
et al. similarly reported a strong association between
antecedent IBS and IBD, an effect that was more pronounced for CD than UC.28 In addition, Porter et al.
previously described an eightfold increase in IBD risk in
those with IBS at baseline compared to those with no
evidence of IBS at baseline, an effect which was twice as
high for CD than UC.9 Others have also observed an
increase in organic GI disorders subsequent to
IBS9, 29, 30; however, the potential mechanisms underlying this association remain poorly characterised. It may
be that an IBS diagnosis represents misdiagnosed IBD, a
potential effect that is confounded by the lack of a diagnostic test for functional bowel disorders.
Stress has been repeatedly evaluated as a potential risk
factor for CD and UC with varying results, likely due to
variability in study design and how stress is measured.31
We observed an increase in UC and CD in those with
more than one life stressor prior to disease. Furthermore,
for UC, the effect appeared to be a positive dose–
Aliment Pharmacol Ther 2017; 45: 1115–1127
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response relationship with increasing UC risk corresponding to an increasing number of life stressors. In a
case–control study of UC risk factors, Tocchi et al.
reported a fourfold increase in the prevalence of a stressful life condition in 12 months prior to study enrolment;
however, due to the study design, a temporal relationship
could not be established.32 Lerebours et al. reported an
association between stressful life events with CD but not
UC; however, exposures were limited to the 6 month
period prior to the onset of symptoms, potentially biasing effect estimates towards the null.33 It may be that the
effect we observed represents increasing symptoms in
undiagnosed patients subsequently leading to treatment
and diagnosis. Increasing symptoms following stress in
IBD patients has been reported previously and studies
have also reported an increase in IBD among those with
depression-like symptoms;34 however, we found no signiﬁcant effect of depression or anxiety on IBD risk.
Of speciﬁc interest in this population is the potential
effect of post-traumatic stress disorder (PTSD) in the
modulation of IBD risk. We reported a slight, albeit not
statistically signiﬁcant, increase in UC and CD risk
among subjects with PTSD; however, the number of
cases with PTSD was quite low. O’Donovan et al.
recently reported on the increase in several autoimmune
disorders among US veterans of war in Iraq and Afghanistan.35 This observation included a signiﬁcant 1.3-fold
increase in the risk of IBD; however, the disease pathotypes were not differentiated. Our study was not powered to identify this effect size; nonetheless, our CIs
include these parameter estimates.
We observed several occupations with signiﬁcantly
increased CD and UC risk. Speciﬁcally, being in a service
and supply category or occupation was associated with
more than a threefold increase in CD risk while a similar
magnitude of UC risk was observed in those whose
occupations included electrical and/or mechanical equipment repair. Occupation risk factors for IBD were
recently summarised by Lesso et al.36 In particular, the
authors report several pathotype-speciﬁc risk factors;
however, the authors also note the considerable lack of
quantiﬁable exposure data and highlight the need for
prospective cohort studies with monitored exposures
over time. Importantly, such studies remain difﬁcult for
relatively rare diseases and focused efforts to simply
describe an increased prevalence with speciﬁc occupations may guide additional such focused studies.
Smoking is a well-described risk factor for CD and a
protective factor for UC; we observed nearly a fourfold
increased risk in CD among current smokers and a
Aliment Pharmacol Ther 2017; 45: 1115–1127
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fourfold decreased risk of UC.31 We also saw a nonsigniﬁcant 1.6-fold increase in CD and UC risk among
those who self-reported former smoking. This ﬁnding is
consistent with prior reports that increased CD risk continues many years after quitting smoking, though the
magnitude of the risk decreases.37, 38 Higuchi et al.
reported an increase in UC risk among women within
2 years of smoking cessation, an effect that persisted for
more than 10 years.37 Similarly, Jiang et al. reported current smoking as a protective factor in UC (OR: 0.28,
P < 0.0001) while being an ex-smoker was a risk factor
(OR: 4.36, P = 0.008).39 Despite a previous report of the
relationship between smoking and IBD risk being more
pronounced in females than males,31 we observed similar
effects in our predominately male population. The reason
for the discrepant effects of cigarette smoking remains
elusive and more research in this area is needed in military and other populations.
We observed an inverse dose–response in the risk of
UC among those reporting moderate and heavy alcohol
consumption and no signiﬁcant association between
alcohol consumption and CD risk. Three prior studies
assessed the role of alcohol in IBD and found a similar
decrease in risk.39–41 The potential beneﬁcial effect of
alcohol in preventing UC has been theorised to be associated with phenols present in alcoholic drinks that may
inhibit pro-inﬂammatory cytokines;42 however, studies of
disease activity in IBD patients have reported an increase
in GI symptoms among UC patients consuming alcohol
due to increasing intestinal permeability and subsequent
antigenic exposure.43 Clearly, additional studies on moderate and heavy alcohol consumption and IBD risk are
needed.
This study had some inherent limitations such as
potential misclassiﬁcation from data obtained from
self-reported survey responses; however, many of the
questions embedded in the survey are standardised and
previously validated.13 In addition to self-reported exposures, IBD was identiﬁed from electronic medical
encounter data. Importantly, these outcomes have not
been validated through medical record review. However,
they have been utilised in several other large epidemiologic studies in this population.10, 11 In addition, other
studies in similar populations have shown a high positive
predictive value in the use of these medical billing codes
to accurately identify those with IBD.44 We were unable
to exclude those with other conditions mimicking IBD,
such as coeliac disease or tropical sprue; however, these
outcomes are rare. Despite these limitations, this study
did utilise data from a population-based prospective
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cohort study, with time-varying covariates that enabled
estimation of disease incidence and risk factors.
While many of the ﬁndings reported here conﬁrm
previously published literature on IBD risk factors, we
ﬁnd these conﬁrmatory results reassuring in the context
of the more novel ﬁndings we observed in this study. In
addition, we feel that ongoing IBD research in military
populations is of utmost importance. The US military
population is a cross-section of the general US population. In addition, the majority of the Millennium Cohort
has separated from service and is now part of the civilian
population. Because a stratiﬁed random sample of eligible military personnel are invited to join the Millennium
Cohort Study without regard to any exposures or health
outcomes, internal comparison groups are readily available in this Cohort.
Our ﬁndings contribute to the growing body of literature on the incidence of and risk factors for inﬂammatory bowel disease in a young, healthy subset of the US
population. In addition to highlighting previously
described epidemiologic risk factors, we were able to
quantify the role of selected life stressors, PTSD and
antecedent infectious gastroenteritis on IBD risk. These
are important characteristics to address in this population given operational deployments, often in combat settings, and the high risk of infectious gastroenteritis
during these operations.45 Clearly, additional welldesigned focused research is needed and may include
expansion to additional survey panels within the Millennium Cohort Study, enhanced characterisation of life

stressors and more expanded data on exposures and clinical presentation of disease.
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